Beranda › Fibrilasi Atrium › North Carolina
Uji klinis Fibrilasi Atrium di North Carolina
15 studi untuk Fibrilasi Atrium mencari peserta di lokasi di North Carolina.
Kota di North Carolina
Teks studi resmi (Bahasa Inggris)
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- University of North Carolina, Chapel Hill
- Wake Forest Baptist Health, Winston-Salem
Menerima pesertaFase 3
Usia 22 hingga 85 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT05836987Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Hawthorne Health, Moose Pharmacy of Concord, Concord
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07626411Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- Moses Cone Hospital Operating Corporation dba Cone Health, Lebauer-Brodie Center for Cardiovascular Research, Greensboro
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07175428A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
- Duke Univ Medical Center, Durham
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07217067Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
- Mission Hospital, Asheville
- Novant Health Forsyth Medical Center, Winston-Salem
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT04088071PULSED AF Post-Approval Study
- Duke University Medical Center (DUMC), Durham
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06578104The Fourth Left Atrial Appendage Occlusion Study
- Mission Hospital HCA, Asheville
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT05963698Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Hawthorne Health, Moose Pharmacy of Concord, Concord
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07430956A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
- WakeMed Hospital, Raleigh
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07523750A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
- Duke University Hospital - Cardiology, Durham
Menerima pesertaFase 2
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07625215Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Anthos Investigative Site 1005, Charlotte
- Anthos Investigative Site 9912, Durham
- Anthos Investigative Site 9950, Pinehurst
- dan 2 lainnya
Menerima pesertaFase 3
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT05712200Tracking Results of Ablations to Combat AF Registry Generation 2
- Atrium Health Wake Forest Baptist, Winston-Salem
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT05111015Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- Duke University, Durham
- East Carolina University, Greenville
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT04045665Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- University of North Carolina Medical Center, Chapel Hill
- Presbyterian Medical Center, Charlotte
- Duke University Hospital, Durham
- dan 5 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Mei 2026 · NCT03907046Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter
- Wake Forest Health Sciences, Winston-Salem
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Mar 2026 · NCT06876896Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.